HSBA

1,203.8

+2.99%↑

LLOY

95.08

+2.72%↑

BARC

393.9

+3.92%↑

LSE

8,548

+0.26%↑

STAN

1,617

+3.72%↑

HSBA

1,203.8

+2.99%↑

LLOY

95.08

+2.72%↑

BARC

393.9

+3.92%↑

LSE

8,548

+0.26%↑

STAN

1,617

+3.72%↑

HSBA

1,203.8

+2.99%↑

LLOY

95.08

+2.72%↑

BARC

393.9

+3.92%↑

LSE

8,548

+0.26%↑

STAN

1,617

+3.72%↑

HSBA

1,203.8

+2.99%↑

LLOY

95.08

+2.72%↑

BARC

393.9

+3.92%↑

LSE

8,548

+0.26%↑

STAN

1,617

+3.72%↑

HSBA

1,203.8

+2.99%↑

LLOY

95.08

+2.72%↑

BARC

393.9

+3.92%↑

LSE

8,548

+0.26%↑

STAN

1,617

+3.72%↑

Search

Syncona Ltd

Open

89.7 0.11

Overview

Share price change

24h

Current

Min

89.5

Max

89.7

Key metrics

By Trading Economics

Income

43M

-25M

Sales

-24M

20M

Profit margin

-127.345

Employees

1,215

EBITDA

24M

-25M

Dividends

By Dow Jones

Next Earnings

18 Jun 2026

Market Stats

By TradingEconomics

Market Cap

-28M

556M

Previous open

89.59

Previous close

89.7

Syncona Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

24 Mar 2026, 18:58 UTC

Major Market Movers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 Mar 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 Mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 Mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 Mar 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 Mar 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24 Mar 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 Mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 Mar 2026, 20:58 UTC

Major News Events

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 Mar 2026, 20:50 UTC

Market Talk
Major News Events

Energy & Utilities Roundup: Market Talk

24 Mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

24 Mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24 Mar 2026, 20:25 UTC

Earnings

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 Mar 2026, 20:15 UTC

Market Talk
Major News Events

Global Commodities Roundup: Market Talk

24 Mar 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Sales $378.7M >WOR

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q EPS 92c >WOR

24 Mar 2026, 19:25 UTC

Market Talk
Major News Events

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 Mar 2026, 19:06 UTC

Market Talk
Major News Events

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 Mar 2026, 18:51 UTC

Market Talk
Major News Events

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 Mar 2026, 18:40 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

24 Mar 2026, 18:40 UTC

Market Talk
Major News Events

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 Mar 2026, 18:34 UTC

Major News Events

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 Mar 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 Mar 2026, 18:21 UTC

Market Talk
Major News Events

Silver Snaps 9-Session Losing Streak -- Market Talk

24 Mar 2026, 18:00 UTC

Acquisitions, Mergers, Takeovers

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Comparison

Price change

Syncona Ltd Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Syncona Ltd

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
help-icon Live chat